FPM monthly webinars provide updates for clinical trainees, senior clinicians, policy makers, academics and other health professionals on prevention, diagnosis and treatment of common and serious clinical disorders – both for communicable and non-communicable diseases.
Webinars are free and hosted on Zoom from 4pm UK time on the 4th Monday of each month.
Register at fpm.chandos@gmail.com
Monday 27th April 4pm UK time
Diagnostic and digital solutions to support addressing the SARS-COVID-19 pandemic
Speaker: Mattias Kyhlstedt, CEO of Synergus RWE, Stockholm, Sweden
Global Prevalence of SARS-COVID-19 (Source ECDC)
Discussants
Sarah Andersson, Professor of Health and Welfare Technology and Former Director of the Swedich Institute for Public Health, Mälardalens
Högskola, Eskilstuna, Västerås, Sweden
Bernard Cheung, Editor-in-Chief, Postgraduate Medical Journal (FPM) and Sun Chieh Yeh Heart Foundation Professor in Cardiovascular Therapeutics, University of Hong Kong
Högskola, Eskilstuna, Västerås, Sweden
Bernard Cheung, Editor-in-Chief, Postgraduate Medical Journal (FPM) and Sun Chieh Yeh Heart Foundation Professor in Cardiovascular Therapeutics, University of Hong Kong
Associate Professor Ken Redekop, Editor-in-Chief, Health Policy and Technology (FPM) and Institute for Medical Technology Assessment, Erasmus University, The Netherlands
Professor Donald Singer, President, Fellowship of Postgraduate Medicine, London, UK
Webinar summary
The SARS-CoV2, the cause of the SARS-COVID19 pandemic, poses the greatest challenge for a century for global health care and financial systems. It took only 4 weeks from the initial awareness report on 31st December 2019 about a new viral pneumonia for the World Health Organization to declare SARS-COVID-19 a Public Health Emergency and a further 6 weeks for this to be declared a global pandemic.
This webinar will consider progress in developing diagnostic tests and challenges in use of digital solutions to manage and to prevent the COVID-19 pandemic. COVID-19 Horizon Scanning is a European initiative bringing together expert collaborations to support regulatory processes aimed at reliable diagnostic tests and digital solutions. This initiative involves working with key academic disciplines, industries, consultants, HTA organizations and governments. These issues are highly relevant for health-professional, health industry and health policy audiences in all regions of the world.
